Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: N8O7MY0VNS

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Killer cell immunoglobulin-like receptor 3DL2 antagonist PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, T-Cell, Cutaneous 1 D016410 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297998
FDA SRS N8O7MY0VNS